A promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin

Jian Cheng1 Department of Hematology, Zhongda Hospital, Medical School, Southeast University, Nanjing, People’s Republic of China

Jun Wang2 Department of Hematology and Oncology, Nanjing Children’s Hospital, Nanjing Medical University, Nanjing, People’s Republic of China

Baoan Chen1 Department of Hematology, Zhongda Hospital, Medical School, Southeast University, Nanjing, People’s Republic of ChinaCorrespondencecba8888@hotmail

Guohua Xia1 Department of Hematology, Zhongda Hospital, Medical School, Southeast University, Nanjing, People’s Republic of China

Xiaohui Cai1 Department of Hematology, Zhongda Hospital, Medical School, Southeast University, Nanjing, People’s Republic of China

Ran Liu1 Department of Hematology, Zhongda Hospital, Medical School, Southeast University, Nanjing, People’s Republic of China

Yanyan Ren1 Department of Hematology, Zhongda Hospital, Medical School, Southeast University, Nanjing, People’s Republic of China

Wen Bao1 Department of Hematology, Zhongda Hospital, Medical School, Southeast University, Nanjing, People’s Republic of China

Xuemei Wang3 National Key Laboratory of Bioelectronics (Chien-Shiung Wu Laboratory), Southeast University, Nanjing, People’s Republic of China

show all

A promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date